Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2000
08/03/2000CA2358964A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000CA2357735A1 Modulation of immune response by ribavirin
08/02/2000EP1023904A2 Adjuvants for use in vaccines
08/02/2000EP1023903A1 Use of life attenuated bacteria for the manufacture of a submucosal vaccine
08/02/2000EP1023445A1 Cadherin derived growth factor and the application thereof
08/02/2000EP1023322A1 Novel npy family member
08/02/2000EP1023318A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin
08/02/2000EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000EP1023279A2 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
08/02/2000EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
08/02/2000EP1023066A1 Novel pyrazole and pyrazoline substituted compounds
08/02/2000EP1023060A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
08/02/2000EP0748222B1 Antitussive composition containing an antitussive and benzydamine
08/02/2000CN1261888A 2{4-[4-(4,5-dichloro-2-methylimidazol-1-yl) butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and therapeutic use
08/02/2000CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000CN1261882A Polymorphic form of tachykinin receptor antagonist 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl) phenyl) ethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-5(oxo-1H,4H-1,2,4-triazolo methylmorpholine
08/02/2000CN1261881A 6-azauracil derivatives as IL-5 inhibitors
08/02/2000CN1261795A Compounds and methods
08/02/2000CN1054998C Clearing away heat and toxic material arresting sleeding powder
08/02/2000CN1054997C Chinese medicinal pill for curing asthmoid respiration
08/02/2000CN1054991C Inhalation for cough and asthma and its preparing method
08/02/2000CN1054990C Tongxuanlifei nourishing liquid for curing cold with cough
08/02/2000CN1054978C Proprietary Chinese traditional medicine for curing asthma and its producing process
08/01/2000US6096774 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, intiators and gas generators
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
08/01/2000US6096753 Substituted pyrimidinone and pyridone compounds and methods of use
08/01/2000US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases
08/01/2000US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents
08/01/2000US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics
08/01/2000US6096320 Vaccines with chimeric protein comprising gamma-interferon and leukotoxin derived from pasteurella haemolytica
08/01/2000CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
07/2000
07/27/2000WO2000043781A2 Growth differentiation factor inhibitors and uses therefor
07/27/2000WO2000043495A2 33 human secreted proteins
07/27/2000WO2000043419A2 Exocytosis pathway proteins and methods of use
07/27/2000WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043401A1 Boron steroid mimics and pharmaceutical compositions
07/27/2000WO2000043395A1 Substituted porphyrins
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000WO2000043026A2 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation
07/27/2000WO2000043001A1 Anti-inflammatory agents
07/27/2000WO2000042993A2 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
07/27/2000WO2000042852A1 Compounds and methods
07/27/2000WO2000025723A3 Methods and compositions for the prevention of tolerance to medications
07/27/2000WO2000011171A3 Human rna-associated proteins
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000CA2361276A1 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation
07/27/2000CA2361272A1 33 human secreted proteins
07/27/2000CA2361064A1 Boron steroid mimics and pharmaceutical compositions
07/27/2000CA2359680A1 Kinase inhibitors
07/27/2000CA2359145A1 Exocytosis pathway proteins and methods of use
07/27/2000CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000CA2358093A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/26/2000EP1021549A2 SENSE mRNA THERAPY
07/26/2000EP1021447A1 Pyrrolopyrazolopyrimidine compound and medicine comprising the same
07/26/2000EP1021429A1 Aryl furan derivatives as pde iv inhibitors
07/26/2000EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION
07/26/2000EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS
07/26/2000EP1021196A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
07/26/2000EP1021181A1 Carboxylic acid indole inhibitors of chemokines
07/26/2000CN1261403A Surface exposed proteins from chlamydia pneumoniae
07/26/2000CN1261367A Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
07/26/2000CN1261352A New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists
07/26/2000CN1261277A Novel substituted imidazole compounds
07/26/2000CN1260995A Chinese medicine for treating asthma, chronic bronchitis, pneumonectasis and pneumocardinal diseases
07/26/2000CN1260991A Drops for curing cold
07/26/2000CN1054850C Piperazine compounds used in therapy
07/26/2000CN1054757C Baishi heat-cleaning granule
07/26/2000CN1054752C Anti-virus heat-cleaning oral liquid
07/26/2000CN1054749C Antin sthmatic paper stuck on acupoint
07/26/2000CA2296965A1 Use of bacterium for manufacture of a vaccine
07/25/2000US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
07/25/2000US6093746 Administering creatine
07/25/2000US6093730 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
07/25/2000US6093716 Substituted 2-pyrimidineamines and processes for their preparation
07/25/2000US6093696 N-acetyl-d-thioproline-(o-2,6-dichlorobenzyl)-l-tyrosine, for example; selectively inhibit the alpha 4 subgroup of integrins from binding to their ligands; use in prophylaxis or treatment of immune or inflammatory diseases
07/25/2000US6093561 Human lysophospholipase
07/25/2000US6093532 Method for storing a biological organ transplant graft using a benzisoselen-azoline or -azine compound
07/25/2000CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists
07/20/2000WO2000042072A2 Polypeptide variants with altered effector function
07/20/2000WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response
07/20/2000WO2000042054A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
07/20/2000WO2000042053A1 Derivatives of monosaccharides as cell adhesion inhibitors
07/20/2000WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
07/20/2000WO2000042034A1 Phenanthridine-n-oxides with pde-iv inhibiting activity
07/20/2000WO2000042023A1 Substituted imidazoles, their preparation and use
07/20/2000WO2000042022A1 Benzoheterocycles and their use as mek inhibitors
07/20/2000WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity
07/20/2000WO2000042019A1 6-arylphenanthridines with pde-iv inhibiting activity
07/20/2000WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
07/20/2000WO2000042017A1 Phenanthridine-n-oxides with pde-iv inhibiting activity
07/20/2000WO2000042013A1 Cinnamamide derivatives and drug compositions containing the same